← Open Payments lookup

MARK LYSIAK: Open Payments

NPI 1770284317 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,629 in 69 payments from 32 companies in 2025. Trend: 2023 $3,135 · 2024 $3,577 · 2025 $1,629

Food & beverage: $1,529Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation8$179
Incyte Corporation3$145
E.R. Squibb & Sons, L.L.C.7$135
ABBVIE INC.6$116
Janssen Biotech, Inc.2$95
PFIZER INC.3$65
Takeda Pharmaceuticals U.S.A., Inc.3$63
Genentech USA, Inc.3$56
Adaptive Biotechnologies Corporation2$56
Merck Sharp & Dohme LLC2$55

Products named: OPDIVO, KISQALI, RYBREVANT, clonoSEQ, KEYTRUDA, XPOVIO, Enhertu, SCEMBLIX.

Industry payments across NY — which companies pay providers there.